S. Salvatore, M. Soligo, F. Proietti, S. Citterio, W. Artibani and R. Milani, “Overactive Bladder Syndrome: Considerations in Pharmacotherapy and New Perspectives,” European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 120, No. 2, 2005, pp. 129-133. doi:10.1016/j.ejogrb.2004.10.014

has been cited by the following article:

• TITLE: Oral Desmopressin in the Management of Adults with Nocturia

  AUTHORS: Shahram Gooran, Sevil Nasirmohtaram, Mohammad Ghasem Mohseni, Behzad Narouie

  KEYWORDS: Nocturia, Desmopressin, Arginine Vasopressin

  JOURNAL NAME: Open Journal of Urology, Vol.1 No.4, October 31, 2011

  ABSTRACT: We investigated the efficacy of oral desmopressin in the treatment of adult nocturia. In an analytical study between 2007-2009 in Zahedan-Iran, Thirty patients ≥55 years with verified nocturia (≥two voids/night) were enrolled. Patients with a history of an obstructive cause of nocturia, those with diseases getting worse by the anti-diuretic affect of desmopressin and those with well-defined curable causes (e.g. cystitis) were excluded. Patients received 0.2 mg of oral desmopressin at bed time for a period of 3 weeks. p